William G Powderly

Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment

Mark Bower, Andrew Hill, H. Shoman, 2016, BMJ Open.

Class-sparing regimens for initial treatment of HIV-1 infection.

Lynne Peeples, Richard Haubrich, Susan Swindells, 2008, The New England journal of medicine.